Temozolomide In Acute Myeloid Leukemia: A MGMT Promoter Methylation Status-Based Treatment Stratification

被引:0
|
作者
Medeiros, Bruno C.
Kohrt, Holbrook E.
Rajwanshi, Richa
Gotlib, Jason [1 ]
Coutre, Steven
Liedtke, Michaela [1 ]
Berube, Caroline
Zhang, Melody [1 ]
Arber, Daniel A. [2 ]
Zehnder, James L. [3 ]
机构
[1] Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA
[2] Stanford Univ, Med Ctr, Dept Clin Lab, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1357 / 1358
页数:2
相关论文
共 50 条
  • [41] Assessment of MGMT promoter methylation status in pleomorphic xanthoastrocytoma
    Marucci, Gianluca
    Morandi, Luca
    JOURNAL OF NEURO-ONCOLOGY, 2011, 105 (02) : 397 - 400
  • [42] MGMT Gene Promoter Methylation Status as a Potent Prognostic Factor in Glioblastoma Treated with Temozolomide Chemo-irradiation
    Kim, Y.
    Kim, S.
    Kim, J.
    Cho, J.
    Chang, J.
    Kim, D.
    Lee, K.
    Suh, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S275 - S275
  • [43] Acute Myeloid Leukemia Is Characterized by Wnt Pathway Inhibitor Promoter Methylation
    Griffiths, Elizabeth A.
    Hooker, Craig M.
    McDevitt, Michael A.
    Karp, Judith E.
    Herman, James G.
    Carraway, Hetty E.
    BLOOD, 2008, 112 (11) : 786 - 786
  • [44] Abnormal methylation of GRAF promoter Chinese patients with acute myeloid leukemia
    Qian, Jun
    Qian, Zhen
    Lin, Jiang
    Yao, Dong-ming
    Chen, Qin
    Li, Yun
    Ji, Run-bi
    Yang, Jing
    Xiao, Gao-fei
    Wang, Ya-li
    LEUKEMIA RESEARCH, 2011, 35 (06) : 783 - 786
  • [45] MGMT protein expression and MGMT promoter methylation status in a series of 63 glioblastomas
    Carrato, Cristina
    Balana, Carmen
    Musulen, Eva
    Sanz, Carolina
    Berdiel, Mireia
    Luis Ramirez, Jose
    Javier Sanchez, Jose
    Teixidor, Pilar
    Rosell, Rafael
    Ariza, Aurelio
    VIRCHOWS ARCHIV, 2008, 452 : S160 - S160
  • [46] MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma
    Donson, A. M.
    Addo-Yobo, S. O.
    Handler, M. H.
    Gore, L.
    Foreman, N. K.
    NEURO-ONCOLOGY, 2007, 9 (02) : 189 - 189
  • [47] Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation
    Pietrantonio, F.
    Perrone, F.
    de Braud, F.
    Castano, A.
    Maggi, C.
    Bossi, I.
    Gevorgyan, A.
    Biondani, P.
    Pacifici, M.
    Busico, A.
    Gariboldi, M.
    Festinese, F.
    Tamborini, E.
    Di Bartolomeo, M.
    ANNALS OF ONCOLOGY, 2014, 25 (02) : 404 - 408
  • [48] MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma
    Donson, Andrew M.
    Addo-Yobo, Steven O.
    Handler, Michael H.
    Gore, Lia
    Foreman, Nicholas K.
    PEDIATRIC BLOOD & CANCER, 2007, 48 (04) : 403 - 407
  • [49] Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy
    Dunn, J.
    Baborie, A.
    Alam, F.
    Joyce, K.
    Moxham, M.
    Sibson, R.
    Crooks, D.
    Husband, D.
    Shenoy, A.
    Brodbelt, A.
    Wong, H.
    Liloglou, T.
    Haylock, B.
    Walker, C.
    BRITISH JOURNAL OF CANCER, 2009, 101 (01) : 124 - 131
  • [50] Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy
    J Dunn
    A Baborie
    F Alam
    K Joyce
    M Moxham
    R Sibson
    D Crooks
    D Husband
    A Shenoy
    A Brodbelt
    H Wong
    T Liloglou
    B Haylock
    C Walker
    British Journal of Cancer, 2009, 101 : 124 - 131